CIDARA THERAPEUTICS INC (CDTX)
US1717572069 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 49.572M 310.81% | 64.448M 30.01% | 63.905M -0.84% | 6.392M -90.00% | -100.00% | 46.104M | 115.17M 149.80% | 303.86M 163.84% | 517.7M 70.37% | |||
| EBITDA YoY % growth | -42.066M 41.22% | -33.36M 20.70% | -24.365M 26.96% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -42.255M 41.19% | -33.503M 20.71% | -24.483M 26.92% | -157.859M -544.77% | -106.506M 32.53% | -133.67M -25.50% | -153.233M -14.64% | -110.866M 27.65% | -31.889M 71.24% | 95.472M 399.39% | 288.97M 202.68% | |
| Operating Margin | -85.24% | -51.98% | -38.31% | -2,469.63% | N/A | N/A | N/A | -240.47% | -27.69% | 31.42% | 55.82% | |
| EPS YoY % growth | -16.80 53.59% | -9.60 42.86% | -4.80 50.00% | -24.92 -419.18% | -10.51 57.81% | -9.63 8.40% | -11.08 -15.05% | -5.27 52.47% | -1.81 65.59% | 2.31 227.48% | 7.70 233.11% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -3.78 -372.07% | -5.30 -132.63% | -5.22 -275.71% | -3.54 -44.67% | -1.59 57.87% |
| Revenue Q2Q % growth | 306K -98.26% | -100.00% | -100.00% | -100.00% | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -35.139M -478.51% | -38.76M -262.55% | -38.25M -244.56% | -33.303M -91.46% | -25.704M 26.85% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -2.45 -36.11% | -4.34 | 1.88 | 43.48% |
| Q2 2024 Q2Q % growth | -1.39 50.36% | -3.29 | 1.90 | 57.74% |
| Q1 2024 Q2Q % growth | -2.28 -480.00% | -0.20 | -2.08 | -1,017.65% |
| Q4 2023 Q2Q % growth | -0.80 78.95% | -2.11 | 1.31 | 62.05% |
| Q3 2023 Q2Q % growth | -1.80 -152.94% | -3.32 | 1.52 | 45.70% |
| Q2 2023 Q2Q % growth | -2.80 26.32% | -2.65 | -0.15 | -5.58% |
| Q1 2023 Q2Q % growth | 0.60 111.11% | -0.75 | 1.35 | 180.21% |
| Q4 2022 Q2Q % growth | -3.80 26.92% | -3.42 | -0.38 | -11.21% |
| Q3 2022 Q2Q % growth | 3.40 145.95% | 3.67 | -0.27 | -7.41% |
| Q2 2022 Q2Q % growth | -3.80 -205.56% | -5.71 | 1.91 | 33.47% |
| Q1 2022 Q2Q % growth | -5.40 30.77% | -6.00 | 0.60 | 9.96% |
| Q4 2021 Q2Q % growth | -5.20 46.94% | -7.02 | 1.82 | 25.96% |
| Q3 2021 Q2Q % growth | -7.40 9.76% | -7.38 | -0.02 | -0.30% |
| Q2 2021 Q2Q % growth | 3.60 140.00% | -1.73 | 5.33 | 307.61% |
| Q1 2021 Q2Q % growth | -7.80 15.22% | -5.24 | -2.56 | -48.97% |
| Q4 2020 Q2Q % growth | -9.80 -16.67% | -4.90 | -4.90 | -100.16% |
| Q3 2020 Q2Q % growth | -8.20 -612.50% | -7.67 | -0.53 | -6.85% |
| Q2 2020 Q2Q % growth | -9.00 8.16% | -5.73 | -3.27 | -57.00% |
| Q1 2020 Q2Q % growth | -9.20 23.33% | -6.95 | -2.25 | -32.33% |
| Q4 2019 Q2Q % growth | -8.40 | -8.82 | 0.42 | 4.79% |
| Q3 2019 Q2Q % growth | 1.60 | -5.25 | 6.85 | 130.50% |
| Q2 2019 Q2Q % growth | -9.80 | -11.53 | 1.73 | 15.00% |
| Q1 2019 Q2Q % growth | -12.00 | -12.33 | 0.33 | 2.65% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 441.997K | -441.997K | -100.00% |
| Q2 2024 Q2Q % growth | 302K -96.03% | 4.794M | -4.492M | -93.70% |
| Q1 2024 Q2Q % growth | 8.463M -67.44% | 6.426M | 2.037M | 31.70% |
| Q4 2023 Q2Q % growth | 17.583M 69.41% | 11.773M | 5.81M | 49.35% |
| Q3 2023 Q2Q % growth | 12.718M -68.79% | 8.302M | 4.416M | 53.19% |
| Q2 2023 Q2Q % growth | 7.614M 22.49% | 11.777M | -4.163M | -35.35% |
| Q1 2023 Q2Q % growth | 25.99M 265.59% | 19.057M | 6.933M | 36.38% |
| Q4 2022 Q2Q % growth | 10.379M 43.65% | 10.778M | -399K | -3.70% |
| Q3 2022 Q2Q % growth | 40.744M 475.81% | 36.38M | 4.364M | 12.00% |
| Q2 2022 Q2Q % growth | 6.216M -81.09% | 6.33M | -114K | -1.80% |
| Q1 2022 Q2Q % growth | 7.109M 195.22% | 6.235M | 874K | 14.02% |
| Q4 2021 Q2Q % growth | 7.225M 93.75% | 4.397M | 2.828M | 64.32% |
| Q3 2021 Q2Q % growth | 7.076M 192.88% | 3.001M | 4.075M | 135.79% |
| Q2 2021 Q2Q % growth | 32.863M 868.84% | 18.564M | 14.299M | 77.03% |
| Q1 2021 Q2Q % growth | 2.408M -4.82% | 10.712M | -8.304M | -77.52% |
| Q4 2020 Q2Q % growth | 3.729M 105.45% | 10.419M | -6.69M | -64.21% |
| Q3 2020 Q2Q % growth | 2.416M -87.35% | 4.988M | -2.572M | -51.56% |
| Q2 2020 Q2Q % growth | 3.392M | 5.381M | -1.989M | -36.96% |
| Q1 2020 Q2Q % growth | 2.53M | 2.295M | 235K | 10.24% |
| Q4 2019 Q2Q % growth | 1.815M | 3.706M | -1.891M | -51.03% |
| Q3 2019 Q2Q % growth | 19.1M | 6.12M | 12.98M | 212.09% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 36.16% | 0.85% | 5.99% |
| Revenue | 0% | -94.83% | -33.33% | -37.33% |